WebSep 15, 2008 · The intellectual property acquired will allow Archimedes to significantly extend the applicability of ChiSys®, Archimedes' highly effective proprietary chitosan … WebFeb 10, 2005 · West Pharma 's nasal drug delivery technologies include ChiSys, a proprietary chitosan-based technology for liquids or powders that increases the residence time of drugs on mucosal surfaces and may improve bioavailability, and pectin-based technology designed to overcome the dose 'spiking' problems that can occur with other …
Archimedes licenses chitosan from Ploughshare
WebSep 15, 2008 · The intellectual property acquired will allow Archimedes to significantly extend the applicability of ChiSys®, Archimedes' highly effective proprietary chitosan-based intranasal drug delivery technology. A particular advantage of the new technology is that the effectiveness of ChiSys is maintained at a range of physiological pH, enabling ... WebFeb 2, 2011 · CPU: Intel Core 2 Duo with 2Ghz, AMD Athlon 64 x2 2Ghz. 2 GB RAM. HDD: 9 GB. DVD ROM: 8x. GPU: NVidia 8800GT 512Mb RAM, ATI 3850HD 512Mb RAM. Audio: DirectX 9.0c. Keyboard, Mouse or Microsoft ... philips learning center : login
[REQUEST] Ys: Memories of Celceta · Issue #39 - GitHub
WebChiSys® is the proprietary name given by Archimedes Development Limited to its suite of intellectual property relating to the mucosal delivery of therapeutic agents using chitosan … WebJan 25, 2008 · CHISYS is a canadian trademark and brand of Archimedes Development Limited, Nottingham Science and Technology Park, Nottingham,GB. This trademark was filed to the Canadian Intellectual Property Office on Wednesday, January 3, 2001. The CHISYS is under the trademark classification: Computer & Software Services & Scientific … Web• Managed analytical and stability programs for Chisys™ Team Leader, Preclinical Development ViroPharma Incorporated Mar 2001 - Aug 2002 1 year 6 months. Exton, PA • Directed all analytical ... truth table from equation